Jazz Pharmaceuticals, Inc. (JAZZ)

NASDAQ

$220.50

$+8.62

(+4.07%)

Pre-Market

Jazz Pharmaceuticals, Inc. (JAZZ) Live Price Chart

Last updated: ⁦2026-10-22 12:00:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Jazz Pharmaceuticals, Inc. (JAZZ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $220.50, with a market capitalization of $13.88B and a P/E ratio of 14.63. Over the past 52 weeks, its price has ranged from $128.80 to $266.38. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$13.88B
Open	$211.88
Day's High	$266.38
Day's Low	$0.52
Previous Close	$211.97
Volume	1.88K
Average Volume	889.36K
P/E Ratio	14.63
52-Week High	$266.38
52-Week Low	$128.80
Dividend Yield	--
Earnings Date	--

Jazz Pharmaceuticals, Inc. (JAZZ) Pre-Market Stock Price

Jazz Pharmaceuticals, Inc. (JAZZ) is trading at $220.50 in pre-market trading as of 2026-10-22 11:56:00, up 4.02% ($8.53) from the previous close of $211.97

Pre-market trading shows how investors are pricing JAZZ before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Jazz Pharmaceuticals, Inc. (JAZZ) 7-Day Stock Price Change

Over the past seven days, Jazz Pharmaceuticals, Inc. (JAZZ) moved from $210.39 to $220.50, representing a gain of 4.80% ($10.11).

The stock traded between $206.71 and $220.50 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 757.64 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

JAZZ 52-Week Price Position

Position in Range: 66.7%

52W Low$128.80

52W High$266.38

JAZZ is currently trading at $220.50, placing it 66.7% of the way from its 52-week low of $128.80 to its 52-week high of $266.38. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Jazz Pharmaceuticals, Inc. (JAZZ)?

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Jazz Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	2890
Exchange	NASDAQ
Company Website	https://www.jazzpharmaceuticals.com

How to Buy Jazz Pharmaceuticals, Inc. (JAZZ) Stock on MEXC

Eligible investors can buy real shares of Jazz Pharmaceuticals, Inc. (JAZZ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for JAZZ and Place Your Order

Open the RealStocks trading page and search for JAZZ. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Jazz Pharmaceuticals, Inc. (JAZZ) stock price today?

Jazz Pharmaceuticals, Inc. (JAZZ) is currently trading at $ 220.50, up 4.02% ($8.53) from the previous close of $ 211.97. Intraday prices update in real time during regular trading hours.

2.Is JAZZ stock going up or down today?

As of 2026-10-22 11:56:00, JAZZ is trading at $ 220.50, up 4.02% ($8.53) from its previous close of $ 211.97. The stock has traded between $ 0.52 and $ 266.38 during today’s regular session. Past price movements do not guarantee future results.

3.What is JAZZ pre-market price?

As of 2026-10-22 11:56:00, JAZZ is trading at $ 220.50 in pre-market trading, up 4.02% ($8.53) from the previous close of $ 211.97. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is JAZZ after-hours price?

As of 2026-10-22 11:56:00, JAZZ is trading at $ 211.87 in after-hours trading, down 0.05% ($0.10) from the regular-session close of $ 211.97. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is JAZZ stock trading now?

JAZZ trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does JAZZ sit relative to its 52-week high and low?

Over the past 52 weeks, JAZZ has traded between a low of $ 128.80 and a high of $ 266.38. At $ 220.50, the stock is positioned 66.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Jazz Pharmaceuticals, Inc. in?

Jazz Pharmaceuticals, Inc. (JAZZ) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Jazz Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Jazz Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 13.88B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is JAZZ valued in terms of P/E ratio and EPS?

JAZZ trades at a P/E ratio of 14.63, based on trailing-twelve-month EPS of $ 14.49. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Jazz Pharmaceuticals, Inc. pay a dividend?

Jazz Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.